Delivery Order SPE2DB22D3011-SPE2DB25FQ2JH
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Dexmethylphenidate ER 20 mg capsules (100-count units) with a ceiling value of $1,036.54. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The product will be...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on July 8, 2025, for the supply of Dexmethylphenidate ER 10 mg capsules (100 count) with a ceiling value of $1,606.41. This is a firm fixed-price delivery order with no set-aside designation, executed under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999.99 billion and running through December 2026. The product will be delivered to...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of Dexmethylphenidate ER 20 mg capsules (100 count) with a ceiling value of $1,148.65. This non-competitive, firm fixed-price delivery order is set to conclude on September 12, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a routine pharmaceutical procurement under the company's existing...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of dexmethylphenidate ER 15 mg capsules (100-count bottles) with a ceiling value of $1,444.29. This is a firm fixed-price delivery order issued under a competitive, non-set-aside procurement. The work will be performed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania, with an ultimate completion date of September 5, 2025. This delivery order is a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Dexmethylphenidate ER 15 mg capsules (100-count bottles) with a ceiling value of $1,234.72. This firm fixed-price delivery order represents a competitive award with no set-aside designation and is scheduled for completion by August 8, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Dexmethylphenidate ER 30 mg capsules (100 count) on August 5, 2025, with a ceiling value of $2,111.70 and an ultimate completion date of August 6, 2025. This is a firm fixed price delivery order with no set-aside designation, executed under competitive procedures. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 6, 2025, for the supply of Dexmethylphenidate ER 10 mg capsules (100-count) with a ceiling value of $1,202.32. This competitively awarded, firm fixed-price delivery order represents a non-set-aside procurement and is scheduled for ultimate completion by August 7, 2025. The order will be fulfilled from the vendor's Conshohocken, Pennsylvania facility, where AmerisourceBergen maintains its corporate...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $1,005.97 delivery order on August 27, 2025, for the supply of Dexmethylphenidate ER 10 mg capsules (100 count). This competitively awarded, firm fixed-price contract requires performance at AmerisourceBergen's corporate facility in Conshohocken, Pennsylvania, with an ultimate completion date of August 28, 2025. No set-aside provisions were applied to this award. This delivery order is issued under AmerisourceBergen's existing...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for dexmethylphenidate ER 25 mg capsules (100-count) on August 20, 2025, with a ceiling value of $1,011.21. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor on this order, which is structured as a child contract under a...
- The Defense Logistics Agency awarded a $2,891.34 delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Dexmethylphenidate ER 15 mg capsules (100 count). The contract is firm fixed price with an ultimate completion date of August 8, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This award was competitively awarded with no set-aside designation and represents a child delivery order under a larger contract...
- SPE2DB22D3011Indefinite Delivery Contract
- SPE2DB22D3011-SPE2DB25FQ2JHDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of Dexmethylphenidate Extended Release 10 mg capsules (100-count bottles) with a ceiling value of $1,433.11. This is a firm fixed-price delivery order with no set-aside designation, meaning the award was competitively evaluated. The ultimate completion date is August 22, 2025, and performance will occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This order represents a child contract under AmerisourceBergen's larger pharmaceutical supply relationship with DLA. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at $999,999,999.00 through December 2026, which serves as the underlying vehicle for this delivery order. This prime contract enables AmerisourceBergen to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare systems worldwide. The company's federal contract portfolio demonstrates extensive experience fulfilling medical procurement requirements across multiple therapeutic domains, including neurological treatments, pain management pharmaceuticals, and specialized medical commodities for the Defense Health Agency and other federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.4k | 8/21/25 |